Medpace Holdings Inc (MEDP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

5375 MEDPACE WAY CINCINNATI, OH 45227

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services. The Company offers development plan design, central laboratory, data management and analysis, and pharmacovigilance new drug application submissions. Medpace Holdings also provides clinical human pharmacology and electrocardiography reading support for clinical trials.

Data as of 2020-05-30
Market Cap3.283 Billion Shares Outstanding35.374 Million Avg 30-day Volume303.997 Thousand
P/E Ratio32.4 Dividend Yield EPS2.91
Price/Sales3.685 Price cash flow ratio16.4 Price free cash flow ratio17.0
Book Value20.29 Price to Tangible Book1104.35 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low109.09 / 53.1 Stddev

Are you looking for this stock instead?

View SEC Filings from MEDP instead.

View recent insider trading info

Funds Holding MEDP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MEDP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

7 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CARLEY BRIAN T

  • Director
0 2020-05-15 1

KRAFT ROBERT O.

  • Director
0 2020-05-15 1

MCCARTHY CORNELIUS P. III

  • Director
0 2020-05-15 1

DAVENPORT FRED B JR

  • Director
1,500 2020-05-15 1

KEATING ASHLEY M.

  • Director
0 2020-05-15 1

KING TOM C

  • Director
0 2020-05-15 3

BROWN BRUCE

  • Director
31,951 2020-05-07 0

TROENDLE AUGUST J. PRESIDENT & CEO

  • Officer
  • Director
  • 10% Owner
8,407,409 2020-05-06 8

MEDPACE INVESTORS, LLC

  • 10% Owner
7,790,766 2020-05-06 6

BURWIG SUSAN E EXEC. VP, OPERATIONS

  • Officer
52,179 2020-02-28 2

EWALD STEPHEN P GENERAL COUNSEL & CORP. SECY.

  • Officer
3,336 2020-02-28 3

GEIGER JESSE J CFO & COO, LAB OPERATIONS

  • Officer
6,382 2020-02-28 4

MEDPACE LIMITED PARTNERSHIP

MEDPACE GP LTD

CINVEN CAPITAL MANAGEMENT (V) GENERAL PARTNER LTD

CINVEN CAPITAL MANAGEMENT (V) LIMITED PARTNERSHIP INC

  • 10% Owner
No longer subject to file 2018-08-27 0

MEDPACE LIMITED PARTNERSHIP

MEDPACE GP LTD

  • 10% Owner
22,999,997 2017-06-21 0

FIFTH CINVEN FUND (NO. 1) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 2) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 3) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 4) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 5) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 6) LIMITED PARTNERSHIP

FIFTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

CINVEN MANCO S.A.R.L.

FIFTH CINVEN FUND FCP-SIF

  • 10% Owner
No longer subject to file 2017-06-21 0

BUCKNELL PENELOPE J VP, HUMAN RESOURCES

  • Officer
3,000 2017-05-02 0

NORTON MATTHEW RICHARD

  • Director
0 2016-08-10 0

LESLIE ALEXANDER F S

  • Director
0 2016-08-10 0

RAJAGOPALAN SUPRAJ R

  • Director
0 2016-08-10 0

CINVEN CAPITAL MANAGEMENT (V) GENERAL PARTNER LTD

CINVEN CAPITAL MANAGEMENT (V) LIMITED PARTNERSHIP INC

CINVEN MANCO S.A.R.L.

FIFTH CINVEN FUND FCP-SIF

FIFTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

  • 10% Owner
22,999,997 2016-08-10 0

FIFTH CINVEN FUND (NO. 1) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 2) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 3) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 4) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 5) LIMITED PARTNERSHIP

FIFTH CINVEN FUND (NO. 6) LIMITED PARTNERSHIP

  • 10% Owner
22,999,997 2016-08-10 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KEATING ASHLEY M. - Director

2020-05-15 A 3,858 a 3,858 0.00 direct

CARLEY BRIAN T - Director

2020-05-15 A 3,858 a 3,858 0.00 direct

KRAFT ROBERT O. - Director

2020-05-15 A 3,858 a 3,858 0.00 direct

MCCARTHY CORNELIUS P. III - Director

2020-05-15 A 3,858 a 3,858 0.00 direct

KING TOM C - Director

2020-05-15 A 3,858 a 3,858 0.00 direct

DAVENPORT FRED B JR - Director

2020-05-15 A 3,858 a 3,858 1,500.00 direct

TROENDLE AUGUST J. - Director - Officer - > 10% Owner PRESIDENT & CEO by medpace investors, llc

2020-05-06 M 3,518 $14.41 a 7,790,766 8,407,409.00 indirect

MEDPACE INVESTORS, LLC - > 10% Owner

2020-05-06 M 3,518 $14.41 a 7,790,766 7,790,766.00 direct

TROENDLE AUGUST J. - Director - Officer - > 10% Owner PRESIDENT & CEO by medpace investors, llc

2020-05-06 M 3,518 d 93,969 8,407,409.00 indirect

MEDPACE INVESTORS, LLC - > 10% Owner

2020-05-06 M 3,518 d 93,969 7,790,766.00 direct

Elevate your investments